Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Genmab A (GMAB) Non-Current Assets: 2018-2021

  • Genmab A's Non-Current Assets rose 62.51% to $258.74 in Q2 2021 from the same period last year, while for Jun 2021 it was $258.74, marking a year-over-year increase of 62.51%. This contributed to the annual value of $250.6 million for FY2020, which is 79.55% up from last year.
  • Genmab A's Non-Current Assets amounted to $258.74 in Q2 2021, which was down 100.00% from $250.6 million recorded in Q4 2020.
  • In the past 5 years, Genmab A's Non-Current Assets ranged from a high of $250.6 million in Q4 2020 and a low of $159.21 during Q2 2020.
  • Moreover, its 3-year median value for Non-Current Assets was $123.6 million (2019), whereas its average is $102.7 million.
  • Data for Genmab A's Non-Current Assets shows a peak YoY increase of 79.55% (in 2020) and a maximum YoY decrease of 100.00% (in 2020) over the last 5 years.
  • Genmab A's Non-Current Assets (Quarterly) stood at $113.7 million in 2018, then climbed by 22.79% to $139.6 million in 2019, then spiked by 79.55% to $250.6 million in 2020, then skyrocketed by 62.51% to $258.74 in 2021.
  • Its last three reported values are $258.74 in Q2 2021, $250.6 million for Q4 2020, and $159.21 during Q2 2020.